There is no denial that the demand for high ticket cosmetic surgery is on the decline but non-invasive aesthetic treatments, such as dermal fillers, injections of botulinum toxin, laser hair removal, photorejuvenation, vascular and pigmented lesion treatments are actually on the rise.

Most of these cosmetic interventions became widely available just a few years ago, but they are still holding the demand that has established aesthetic medicine as an endless frontier for fee-for-service business. In today’s economic recession, it is clear that even this business is affected, as many consumers are re-evaluating their cosmetic surgery plans and the money they will spend on them, in addition to applying higher scrutiny upon the services they purchase.

According to a recent poll by the American Society of Plastic Surgeons (ASPS), 27 percent of patient respondents were considering less expensive cosmetic options, compared with 20 percent six months ago. And while their planned expenditure may be less, the expectations of the consumer have not diminished. It is the promise of turning back the hands of time that continue to lure the consumer. But when cold hard cash is involved — especially during pressing financial times — practitioners have to deliver and their aesthetic outcomes must live up to the consumer’s expectations.

One of the ways to cope with the pressure of the consumer expectations is to focus on a few treatments, which you know the best and actually like to do. It is hard to be a master of all arts in aesthetic medicine and there are lots of jacks in the art of litigation who are also hungry for your patient’s cold cash.